1362
Can. J. Chem. Vol. 89, 2011
7.05–7.14 (m, 3H), 7.35–7.52 (m, 5H), 11.79 (s, 1H). MS
(EI): m/z 251 (M+).
1H), 7.29 (d, 1H, J = 8.8 Hz), 7.35 (d, 1H, J = 2.4 Hz),
7.58 (dd, 1H, J = 2.4 and 8.8 Hz), 7.84 (d, 1H, J =
8.8 Hz), 7.97 (d, 1H, J = 8.8 Hz). 13C NMR (DMSO-d6) d:
31.2, 56.0, 113.8, 116.7, 119.5, 121.0, 122.6, 123.0, 123.3
(q), 124.5, 126.1, 127.0, 129.1, 130.6, 140.7, 145.8, 154.5,
4-m-Tolylquinolin-2(1H)-one (16, 92909-30-4)8c
FTIR (neat, cm–1): 1038, 1160, 1271, 1385, 1432, 1547,
1
157.1. MS (EI): m/z 445 (M+), 447 (M+ + 2), 449 (M+
+
1606, 1654, 2836, 3316. H NMR (DMSO-d6) d: 2.36 (s,
3H), 6.34 (s, 1H), 7.08–7.13 (m, 1H), 7.20–7.41 (m, 7H),
4). Anal. calcd for C18H12BrClF3NO2: C 48.40, H 2.71, N
3.14; found: C 48.35, H 3.02, N 3.18.
11.85 (s, 1H). MS (EI): m/z 235 (M+).
4-p-Tolylquinolin-2(1H)-one (17, 106015-76-3)8c
(2E)-Ethyl-3-(4-(5-chloro-2-methoxyphenyl)-6-
(trifluoromethyl)-1,2-dihydro-1-methyl-2-oxoquinolin-3-yl)
acrylate (4)
FTIR (neat, cm–1): 1039, 1383, 1433, 1502, 1608, 1664,
1
2850, 3319. H NMR (DMSO-d6) d: 2.40 (s, 3H), 6.35 (s,
FTIR (neat, cm–1): 1132, 1286, 1371, 1494, 1620, 1662,
1695, 3111.1H NMR (CDCl3) d: 1.25 (t, 3H), 3.69 (s, 3H),
3.84 (s, 3H), 4.16 (q, 2H), 7.02 (d, 1H, J = 9.1 Hz), 7.08
(d, 1H, J = 2.4 Hz), 7.27 (s, 1H), 7.35 (d, 2H, J = 2.4 Hz),
7.58 (m, 2H), 7.80 (d, 1H, J = 9.1 Hz). 13C NMR (75 MHz,
CDCl3, TMS) d: 14.1, 30.1, 55.9, 60.3, 112.8, 114.8, 120.0,
124.1, 124.4, 125.1, 125.3, 125.4, 125.5, 126.1, 127.5(q),
130.1, 130.8, 137.4, 141.1, 147.0, 155.0, 160.4, 167.5. MS
(EI): m/z 465 (M+), 467 (M+ + 2). Anal. calcd for
C23H19ClF3NO4: C 59.30, H 4.11, N 3.01; found: C 59.29,
H 4.26, N 3.08.
1H), 7.13 (t, 1H, J = 7.7 and 7.9 Hz), 7.35–7.41 (m, 6H),
7.52 (t, 1H, J = 7.9 and 7.2 Hz), 11.82 (s, 1H). MS (EI): m/z
235 (M+).
4-Phenyl-2H-chromen-2-one (18, 15185-05-4)10
FTIR (neat, cm–1): 1365, 1444, 1491, 1560, 1606, 1734,
1
3072. H NMR (CDCl3) d: 6.36 (s, 1H), 7.22 (t, 1H, J =
7.7 Hz), 7.40–7.57 (m, 8H). MS (EI): m/z 222 (M+).
4-p-Tolyl-2H-chromen-2-one (19, 76103-24-7)10
FTIR (neat, cm–1): 1365, 1510, 1608, 1726, 3070. 1H
NMR (CDCl3) d: 2.45 (s, 3H), 6.36 (s, 1H), 7.20 (d, 1H,
J = 7.6 Hz), 7.23 (d, 1H, J = 7.6 Hz), 7.34 (m, 4H), 7.54
(m, 2H). MS (EI): m/z 236 (M+).
Acknowledgment
The authors are thankful to the Department of Science and
Technology (DST) and Council of Scientific and Industrial
Research (CSIR), New Delhi, India for their financial sup-
port.
4-(4-Methoxyphenyl)-2H-chromen-2-one (20, 170456-76-5)10
FTIR (neat, cm–1): 1294, 1599, 1491, 1670, 1757, 3072.1H
NMR (CDCl3) d: 3.90 (s, 3H), 6.36 (s, 1H), 7.05 (d, 2H, J =
8.5 Hz), 7.25 (t, 1H), 7.42 (m, 3H), 7.56 (t, 2H, J = 8.5 Hz).
MS (EI): m/z 252 (M+).
References
(1) (a) Gurjar, M. K.; Sharma, G. V. M.; Ilangovan, A.;
Narayanan, V. US Patent 6,191,279, 2001; (b) Thal, C.;
Boye, O.; Guenard, D.; Potier, P. Int. Patent WO 9002733,
1990; (c) Hewawasam, P.; Starrett, J. E., Jr.; Swartz, S. G. Int.
Patent WO 9909983, 1999; (d) Shogaki, T.; Toyoda, H.;
Kakita, T.; Furukawa, M.; Nakatsugi, S.; Masai, E.; Yashima,
T.; Ueda, I. Patent EP 577325, 1994; (e) Suzuki, K.; Fujiwara,
S.; Machii, D.; Ochifuji, N.; Takai, H.; Oono, T.; Furuta, S.;
Yamada, K. Patent JP 06092939, 1994; (f) Komatsu, M.;
Uchida, M.; Nishi, T.; Ishikawa, H.; Kuroda, T.; Tsuji, K.
Patent JP 08295673, 1996.
(2) (a) Goodell, J. R.; Puig Basagoiti, F.; Forshey, B. M.; Shi, P.
Y.; Ferguson, D. M. J. Med. Chem. 2006, 49 (6), 2127. doi:10.
1021/jm051229y; (b) Arcadi, A.; Cacchi, S.; Fabrizi, G.;
Manna, F.; Pace, P. Synlett 1998, 1998 (4), 446. doi:10.1055/s-
1998-1656; (c) Godard, A.; Fourquez, J. M.; Tamion, R.;
Marsais, F.; Queguiner, G. Synlett 1994, 1994 (4), 235. doi:10.
1055/s-1994-22807; (d) Anzini, M.; Cappelli, A.; Vomero, S.
J. Heterocycl. Chem. 1991, 28 (7), 1809. doi:10.1002/jhet.
5570280727.
(3) (a) Hewawasam, P.; Fan, W.; Ding, M.; Flint, K.; Cook, D.;
Goggins, G. D.; Myers, R. A.; Gribkoff, V. K.; Boissard, C.
G.; Dworetzky, S. I.; Starret, J. E.; Lodge, N. J. J. Med. Chem.
2003, 46 (14), 2819. doi:10.1021/jm030005h; (b) Cappelli, A.;
Pericot Mohr, G.; Gallelli, A.; Rizzo, M.; Anzini, M.; Vomero,
S.; Mennuni, L.; Ferrari, F.; Makovec, F.; Menziani, M. C.; De
Benedetti, P. G.; Giorgi, G. J. Med. Chem. 2004, 47 (10),
2574. doi:10.1021/jm031100t; (c) Angibaud, P. R.; Venet, M.
G.; Filliers, W.; Broeckx, R.; Ligny, Y. A.; Muller, P.;
Poncelet, V. S.; End, D. W. Eur. J. Org. Chem. 2004, 2004 (3),
479. doi:10.1002/ejoc.200300538; (d) Andresen, B. M.;
4-(5-Chloro-2-hydroxyphenyl)-6-(trifluoromethyl)quinolin-2
(1H)-one (24)
FTIR (neat, cm–1): 1437, 1558, 1653, 3311. 1H NMR
(DMSO-d6) d: 6.49 (s, 1H), 7.02 (d, 1H, J = 8.8 Hz), 7.30–
7.35 (m, 3H), 7.52 (d, 1H, J = 8.8 Hz), 7.81 (d, 1H, J =
8.5 Hz), 10.11 (s, 1H), 12.2 (s, 1H). 13C NMR (DMSO-d6)
d: 116.5, 117.3, 117.9, 121.6, 122.0, 122.8, 123.6(q), 124.6,
126.4, 126.5, 129.6, 130.1, 141.1, 147.9, 153.2, 161.4. MS
(EI): m/z 339 (M+) 341 (M++2). Anal. calcd for
C16H9ClF3NO2: C 56.57, H 2.67, N 4.12; found: C 56.59, H
2.87, N 4.17.
4-(5-Chloro-2-methoxyphenyl)-6-(trifluoromethyl)-1-
methylquinolin-2(1H)-one (25)
FTIR (neat, cm–1): 1305, 1494, 1602, 1674, 2845, 3055.1H
NMR (DMSO-d6) d: 3.68 (s, 3H), 3.71 (s, 3H), 6.66 (s, 1H),
7.24 (s, 1H), 7.27 (d, 1H, J = 7.0 Hz), 7.40 (d, 1H, J =
2.4 Hz), 7.58 (dd, 1H, J = 8.8 and 2.4 Hz), 7.79 (d, 1H,
J = 8.8 Hz), 7.94 (d, 1H, J = 8.8 Hz). 13C NMR (DMSO-
d6) d: 29.4, 55.8, 113.5, 116.4, 119.0, 122.9, 123.6, 124.7,
125.9, 126.8, 129.7, 130.5, 141.8, 146.1, 155.0, 160.5. MS
(EI): m/z 367 (M+), 369 (M+ + 2). Anal. calcd for
C18H13ClF3NO2: C 58.79, H 3.56, N 3.81; found: C 58.81,
H 3.68, N 3.81.
3-Bromo-4-(5-chloro-2-methoxyphenyl)-6-(trifluoromethyl)-
1-methylquinolin-2(1H)-one (26)
FTIR (neat, cm–1): 1120, 1311, 1491, 1654, 2848, 2941.
1H NMR (DMSO-d6) d: 3.36 (s, 3H), 3.81 (s, 3H), 7.19 (s,
Published by NRC Research Press